UK markets open in 2 hours 12 minutes
  • NIKKEI 225

    28,284.92
    -48.60 (-0.17%)
     
  • HANG SENG

    24,113.51
    -104.52 (-0.43%)
     
  • CRUDE OIL

    85.01
    +1.19 (+1.42%)
     
  • GOLD FUTURES

    1,817.30
    +0.80 (+0.04%)
     
  • DOW

    35,911.81
    -201.79 (-0.56%)
     
  • BTC-GBP

    30,880.40
    -518.98 (-1.65%)
     
  • CMC Crypto 200

    1,008.84
    -16.89 (-1.65%)
     
  • ^IXIC

    14,893.75
    +86.95 (+0.59%)
     
  • ^FTAS

    4,292.58
    +35.99 (+0.85%)
     

EUROBIO SCIENTIFIC LAUNCHES THE EXCLUSIVE DISTRIBUTION OF THE FIRST SALIVA SELF-TEST FOR HIV TESTING IN FRANCE

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

EUROBIO SCIENTIFIC LAUNCHES THE EXCLUSIVE DISTRIBUTION OF
THE FIRST SALIVA SELF-TEST FOR HIV TESTING IN FRANCE

OraQuick®: first rapid saliva self-test for HIV screening for point-of-care biology, including pharmacies

Paris, January 11, 20225:45pm

Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), a leading French group in specialty in vitro medical diagnostics, announces that it entered into an exclusive distribution contract for the commercialization of OraQuick®, a saliva self-test, with Orasure, a US company. This exclusive contract includes the French market and its overseas territories.

OraQuick® is a CE marked rapid test that can detect the presence of antibodies characteristic of HIV infections in 20 minutes from a saliva sample. Like the COVID serological tests, it includes a small plate with a window to view the result. It does not require a blood sample but a simple saliva sample drawn with a palette also provided for this purpose.

In France, an estimated 173,000 people are infected with HIV, 24,000 of whom are unaware of their infection. Currently, more than 25% of HIV tests are carried out on late stage infections. The availability of rapid screening tests that are easy to implement is therefore essential to encourage self-screening in all discretion.

OraQuick® is immediately available in pharmacies and for hospital or non-profit organizations screening centers. With this test, Eurobio Scientific is strengthening its presence in point-of-care biology, particularly in pharmacies, and expanding its range of self-tests, its COVID self-test being already available since June 2021.

Next financial meeting
2021 FY revenues: 24 January 2022

Attachment


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting